The role of nitric oxide in the failing heart

Heart Failure Reviews

Volumn 6, Issue 2, 2001, Pages 105-118

  Paulus, Walter J ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Diastole; Heart failure; Myocardium; Nitric oxide; Nitric oxide synthase; Remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SUPEROXIDE;

AGING; ANION TRANSPORT; CALCIUM HOMEOSTASIS; DIABETES MELLITUS; DIASTOLE; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM; ENERGY METABOLISM; GENE EXPRESSION; GRAFT REJECTION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART PRELOAD; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; REVIEW;

APOPTOSIS; DIASTOLE; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN CONSUMPTION; UP-REGULATION;

EID: 0035059318     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011453809750     Document Type: Review

References (95)

1. Nitrovasodilators have (small) direct effects on cardiac contractility. Is this important?
2. Nitric oxide and cardiac contraction: Clinical studies
3. Nitric oxide attenuates cardiac myocyte contraction
4. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans
5. Effects of NO-donors on LV diastolic function in patients with severe pressure-overload hypertrophy
6. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction
7. Paracrine coronary endothelial control of left ventricular function in humans
8. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation
9. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of β-adrenergic inotropic responsiveness
10. Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to β-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy
11. Factors released from endothelium of the ferret and pig modulate myocardial contraction
12. Atriopeptin III induces early relaxation of isolated mammalian papillary muscle
13. Effects of the nitric oxide donor sodium nitroprusside on intercellular pH and contraction in hypertrophied myocytes
14. 2+ in intact cardiac myocytes
15. Lipopolysaccharide induces cell shrinkage in rabbit ventricular cardiac myocytes
16. cGMP and atrial natriuretic factor regulate cell volume of rabbit atrial myocytes
17. Coronary endothelium dysfunction and heart failure
18. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart
19. Mechanical transduction of nitric oxide synthesis in the beating heart
20. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats
21. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy
22. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog
23. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve
24. The molecular energetics of the failing heart from animal models
25. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs
26. Nitric oxide modulates mitochondrial respiration in failing human heart
27. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes
28. Sfingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte
29. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide
30. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart
31. Apoptosis in myocytes in end-stage heart failure
32. Apoptosis in the failing human heart
33. The role of cell death in heart failure
34. Nitric oxide as a bi-functional regulator of apoptosis
35. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis
36. Cytokin-mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation
37. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x
38. Enzymatic functions of nitric oxide synthases
39. Peroxynitrite, the breakdown product of nitric oxide, is beneficial in blood cardioplegia but injurious in crystalloid cardioplegia
40. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic. Role of tumor necrosis factor-α
41. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
42. Molecular inotropy. A future approach to the treatment of heart failure?
43. Endotoxin and pro-inflammatory cytokines impair α-MHC and MCK expression in cardiamyocytes in part by an E-box dependent mechanism
44. Decreased myocardial nNOS, increased iNOS and abnormal ECG's in mouse models of Duchenne muscular dystrophy
45. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy
46. Heterogeneous basal expression of nitric oxide synthase and superoxide dismutase isoforms in mammalian heart
47. Increased production of nitric oxide in coronary arteries during congestive heart failure
48. Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts
49. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy
50. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND Study
51. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart
52. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthase in end-stage human heart failure. Their relation to lesion site and β-adrenergic receptor therapy
53. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure
54. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension
55. Nitric Oxide Synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart
56. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (Type 3) in cardiac myocytes
57. ++-independent nitric oxide synthase in the myocardium
58. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
59. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
60. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics
61. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis
62. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
63. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs
64. Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs
65. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure
66. Nitric oxide synthase activities in human myocardium
67. Induction of nitric oxide synthase in the human allograft is associated with contractile dysfunction of the left ventricle
68. Expression of inducible nitric oxide synthase in human heart failure
69. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft
70. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy
71. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes
72. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β
73. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1
74. C-Myc expression and its role in patients with chronic aortic regurgitation
75. Loss of gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
76. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart
77. Matrix metalloproteinase inhibition during the development of congestive heart failure. Effects on left ventricular dimensions and function
78. Activation of matrix metalloproteinases in the failing human heart. Breaking the tie that binds
79. Regulation of stroke volume during exercise in patients with severe left ventricular dysfunction: Importance of the Starling mechanism
80. Existence of the Frank-Starling mechanism in the failing human heart
81. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler enchocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications
82. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: Relation to symptoms and prognosis
83. Left ventricular end-diastolic wall stress and endomyocardial inducible nitric oxide syntase gene expression in human dilated cardiomyopathy
84. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs
85. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression
86. Effect of endurance training on atrial natriuretic peptide gene expression in normal and hypertrophied hearts
87. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart
88. Chronic L-NAME-induced hypertension: Novel molecular adaptation to systolic load in absence of hypertrophy
89. Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy
90. Coronary microvascular endothelial cell redox state in left ventricular hypertrophy. The role of angiotensin II
91. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production
92. Gene expression of antioxidative enzymes in the human heart
93. Proinflammatory cytokines depress cardiac efficiency by nitric oxide dependent mechanism
94. Myocardial contractile response to nitric oxide and cGMP
95. Ischemic cardiomyopathy: Endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease